Position in PFE
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$465,297
-$53,677 QoQ
Shares Held
19,323
+4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#1,803
of 2,821 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2024CallValue
$119,385
CallShares
4,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caitlin John, LLC holds $1,198,679 across 12 Drug Manufacturers - General names. PFE ranks #1 (38.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
This page
|
19,323 | $465,297 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
3,822 | $220,222 | |
| 3 | JNJ |
Johnson & Johnson
|
539 | $136,888 | |
| 4 | MRK |
Merck & Co., Inc.
|
876 | $112,566 | |
| 5 | AMGN |
Amgen Inc
|
255 | $92,340 | |
| 6 | LLY |
ELI LILLY & Co
|
53 | $63,569 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
351 | $44,345 | |
| 8 | ABBV |
AbbVie Inc.
|
149 | $37,494 |
All Filings in PFE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $465,297 | 19,323 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $518,974 | 18,482 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $436,671 | 17,537 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $425,158 | 16,686 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $302,466 | 12,478 | Shares | Defined | 2025-07-14 | |
| 2024-12-31 | $100,495 | 3,788 | Shares | Sole | 2025-01-27 | |
| 2024-12-31 | $119,385 | 4,500 | Call | Sole | 2025-01-27 | |
| 2024-09-30 | $188,110 | 6,500 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $614,714 | 21,241 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $207,052 | 7,400 | Call | Sole | 2025-01-27 | |
| 2024-06-30 | $615,643 | 22,003 | Shares | Sole | 2025-01-27 | |
| 2024-03-31 | $132,922 | 4,790 | Shares | Sole | 2025-01-27 | |
| 2023-12-31 | $87,492 | 3,039 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||